Wen Hsuan Hsieh Sells 413,146 Shares of Amprius Technologies (NYSE:AMPX) Stock

Amprius Technologies, Inc. (NYSE:AMPX) Director Wen Hsuan Hsieh sold 413,146 shares of the business’s stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $18.44, for a total value of $7,618,412.24. Following the completion of the sale, the director owned 44,444 shares of the company’s stock, valued at $819,547.36. This trade represents a 90.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Amprius Technologies Price Performance

Shares of NYSE AMPX opened at $17.93 on Friday. The firm has a market cap of $2.46 billion, a price-to-earnings ratio of -52.72 and a beta of 3.04. The stock’s fifty day moving average price is $11.88 and its two-hundred day moving average price is $11.10. Amprius Technologies, Inc. has a one year low of $1.80 and a one year high of $19.40.

Amprius Technologies (NYSE:AMPX) last posted its earnings results on Wednesday, March 4th. The company reported ($0.01) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.03. The company had revenue of $25.23 million during the quarter, compared to the consensus estimate of $22.91 million. Amprius Technologies had a negative return on equity of 24.29% and a negative net margin of 60.30%.Amprius Technologies has set its FY 2026 guidance at –0.060 EPS. On average, equities analysts anticipate that Amprius Technologies, Inc. will post -0.45 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Amprius Technologies

Hedge funds have recently bought and sold shares of the company. Bank of America Corp DE raised its position in shares of Amprius Technologies by 31.1% in the 4th quarter. Bank of America Corp DE now owns 12,890 shares of the company’s stock valued at $36,000 after buying an additional 3,055 shares in the last quarter. Ameritas Investment Partners Inc. boosted its position in shares of Amprius Technologies by 2,043.2% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 9,516 shares of the company’s stock worth $40,000 after acquiring an additional 9,072 shares in the last quarter. Quarry LP bought a new position in Amprius Technologies in the third quarter valued at approximately $42,000. Rhumbline Advisers increased its stake in Amprius Technologies by 61.1% in the first quarter. Rhumbline Advisers now owns 15,690 shares of the company’s stock valued at $42,000 after acquiring an additional 5,951 shares during the last quarter. Finally, Legal & General Group Plc raised its position in Amprius Technologies by 1,385.4% during the second quarter. Legal & General Group Plc now owns 10,383 shares of the company’s stock valued at $44,000 after purchasing an additional 9,684 shares in the last quarter. 5.04% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on AMPX shares. B. Riley Financial increased their target price on shares of Amprius Technologies from $16.00 to $22.00 and gave the stock a “buy” rating in a research report on Monday, March 9th. William Blair reiterated an “outperform” rating on shares of Amprius Technologies in a research report on Friday, March 6th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Amprius Technologies in a research note on Wednesday, January 21st. Needham & Company LLC reissued a “buy” rating and set a $20.00 price target on shares of Amprius Technologies in a research report on Tuesday, March 10th. Finally, Cantor Fitzgerald raised their price objective on Amprius Technologies from $16.00 to $20.00 and gave the stock an “overweight” rating in a research note on Friday, March 6th. Eight research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $19.75.

Key Headlines Impacting Amprius Technologies

Here are the key news stories impacting Amprius Technologies this week:

• Positive Sentiment: Northland Securities raised Q1 EPS estimates for AMPX, improving near-term earnings visibility and giving bulls a fundamental reason to buy. Q1 EPS Estimates for AMPX Increased by Northland Securities
• Positive Sentiment: Needham & Company reaffirmed its Buy rating on AMPX (and other brokers have raised targets or reiterated buys), adding analyst-level validation that can attract institutional and retail inflows. Needham & Company LLC Reaffirms Buy Rating for Amprius Technologies (NYSE:AMPX)
• Neutral Sentiment: Coverage summarizing Northland’s forecast for AMPX Q4 earnings provides modeling context for investors but is informational until tied to company guidance or additional upgrades. What is Northland Securities’ Forecast for AMPX Q4 Earnings?
• Negative Sentiment: Director Steven Chu sold 155,565 shares on March 12 at an average price of $18.50 (~$2.88M), cutting his holdings by roughly 55% — a large insider sale that can be interpreted as a negative signal and may create short-term downward pressure. SEC Filing: Steven Chu Sale (3/12)
• Negative Sentiment: On March 10 the same director sold another 166,632 shares at an average of $17.92 (~$2.99M). The consecutive large sales amplify the negative signaling despite possible non-operational reasons (tax, diversification). SEC Filing: Steven Chu Sale (3/10)

About Amprius Technologies

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.